Stromelysin-1 (MMP-3) is associated with all cause mortality and heart failure post acute myocardial infarction

被引：0

作者：

Kelly, D. ^{[1
]}

Cockerill, G. ^{[2
]}

Ng, L. ^{[2
]}

Thompson, M. ^{[1
]}

Samani, N. ^{[2
]}

Squire, I. ^{[2
]}

机构：

[1] Univ Hosp Leicester, Leicester, Leics, England

[2] Univ London St Georges Hosp, Sch Med, London SW17 0RE, England

来源：

EUROPEAN HEART JOURNAL | 2007年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：785 / 785

页数：1

共 50 条

[31] Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation [J].

Silence, J ;

Lupu, F ;

Collen, D ;

Lijnen, HR .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) :1440-1445

[32] The effect of eplerenone on all-cause mortality and heart failure hospitalization in the Eplerenone Post-acute myocardial infarction Heart failure Efficacy and Survival Study (EPHESUS) [J].

Zannad, F ;

Gheorghiade, M ;

Krum, H ;

Chu, TC ;

Patni, R ;

Pitt, B .

JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) :S76-S76

[33] Stromelysin-1 (MMP-3) regulation by big ET-1 (1-38) in human OA chondrocytes [J].

Roy-Beaudry, M ;

Martel-Pelletier, J ;

Filep, J ;

Pelletier, JP ;

Shipkolye, F ;

Moldovan, F .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 :115-115

[34] Myocardial hibernation as a cause of heart failure in acute myocardial infarction [J].

Kiyak, J ;

Tshngryan, G ;

Zhukovsky, Y .

ADVANCES IN HEART FAILURE, 2002, :147-150

[35] The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease [J].

D'Souza, CA ;

Mak, B ;

Moscarello, MA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13589-13596

[36] Vitamin D-3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C [J].

Schmitz, JP ;

Schwartz, Z ;

Sylvia, VL ;

Dean, DD ;

Calderon, F ;

Boyan, BD .

JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 168 (03) :570-579

[37] MMP-3 (stromelysin-1) expression is variable in both tumor and stromal cells in malignant pleural mesothetioma (MPM) [J].

Scott, K ;

Rankin, C ;

Borden, E ;

McKinney, L ;

Dexter, E ;

Benson, K ;

Bowden, GT ;

Nagte, R ;

Garland, L .

LUNG CANCER, 2004, 46 :S85-S86

[38] Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT) [J].

Blavier, Laurence ;

Lazaryev, Alisa ;

Shi, Xiang-He ;

Dorey, Frederick J. ;

Shackleford, Gregory M. ;

DeClerck, Yves A. .

CANCER BIOLOGY & THERAPY, 2010, 10 (02) :198-208

[39] The constituent tryptophans and bisANS as fluorescent probes of the active site and of a secondary binding site of stromelysin-1 (MMP-3) [J].

Dennis E. Epps ;

Roger A. Poorman ;

Gary L. Petzold ;

Christopher W. Stuchly ;

Alice L. Laborde ;

John H. Van Drie .

Journal of Protein Chemistry, 1998, 17 :699-712

[40] Genetic variation in MMP-3 (stromelysin), phenotype and clinical outcomes in patients with congestive heart failure [J].

Shah, AN ;

Tobelmann, P ;

Afari-Armah, N ;

Sheppard, R ;

Cadaret, L ;

Ramani, R ;

MacGowan, G ;

Mathier, M ;

Murali, S ;

London, B ;

McNamara, DM .

CIRCULATION, 2004, 110 (17) :555-555

← 1 2 3 4 5 →